Announcement on Resolution of the 2024 Annual General Meeting
Filed with SSE · · 5 pages · Chinese
Aurisco Pharmaceutical Co. Ltd. on 6ix
Earlier from Aurisco Pharmaceutical
- Announcement on Change in Bondholders' Holding Ratio of Convertible Bonds Reaching 10%
- Announcement on Progress of Using Some Idle Raised Funds for Cash Management
- Announcement on Redemption upon Maturity of Some Idle Raised Funds Used for Cash Management
- Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
Later from Aurisco Pharmaceutical
- Indicative Announcement on Suspending Conversion of "Aurisco Convertible Bonds" during Implementation of Dividend Distribution for 2024
- Announcement on Adjusting the Total Cash Dividends for Profit Distribution in 2024
- Announcement on Adjusting Upper Limit of Shares Repurchase Price after Implementing Dividend Distribution for 2024
- Announcement on Passing On-site Inspection by FDA
- Announcement on 2025 Tracking Credit Rating Results of "Aurisco Convertible Bonds"
Follow Aurisco Pharmaceutical into a list and get an email when it puts out news.
Follow Aurisco Pharmaceutical